Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-21-000487
Filing Date
2021-06-04
Accepted
2021-06-04 16:49:01
Documents
2
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1616
2 POA attachment_1.htm EX-24 3103
  Complete submission text file 0001192482-21-000487.txt   6090
Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Issuer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O BIOVENTUS INC. 4721 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address
Nosenzo John (Reporting) CIK: 0001835973 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39130 | Film No.: 21997097